Dental Pulp Derived Stem Cells: Optimizing Collection and Cryopreservation
Dental Pulp Derived Stem Cells: Optimizing Collection and Cryopreservation
批准号:
7482180
负责人:
ERIK J. WOODS
金额:
$10.61万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-15 至 2008-10-14
关键词:
Biological AssayCellsCharacteristicsClinicClinicalCollectionConditionCryopreservationDataDental PulpDevelopmentDigestionEmbryoEquipmentFreezingGoalsGuanosine TriphosphateHistocompatibility TestingHumanHuman ResourcesMeasuresMediatingMethodsPhasePhase I Clinical TrialsPliabilityPopulationPreparationProceduresProcessPublic HealthRecoveryRecovery of FunctionResearchResearch PersonnelSamplingSourceStem Cell ResearchStem cellsSterilization for infection controlTestingTherapeutic UsesTimeTissue EngineeringTissuesTooth structureTransplantationTransportationadult stem cellcell banklaboratory manualsprotocol developmentstem
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this application is to develop an understanding of the collection, processing and cryobiological characteristics of stem/progenitor cells recovered from extracted teeth with the ultimate culmination of these data to allow for a cryobank of Dental pulp derived stem cells (DPSCs) for research and/or potential transplant or other clinical utilization as a human cell product processed under current good tissue practice (cGTP) as described under 21 CFR 1271. Recent studies investigating this exciting source of post-natal stem cells have identified a population of clonogenic and highly proliferative cells derived from enzymatically digested Dental pulp tissue (Gronthos, et al., 2000). Results from these studies have indicated that these cells may have the potential to be utilized in stem cell mediated therapies and tissue engineering applications (Seo, et al., 2005). To allow further study and potential therapeutic use of these cells, investigators have just begun to evaluate the ability of these cells and their respective tissues of origin to survive cryopreservation processing. Ideally, the optimum cryopreservation process will be straight forward and effective when applied to the tissue as a whole, with the idea that stem cells could be extracted post-thaw. The rationale for this would be to preserve clinical samples for subsequent stem cell recovery as it is reasonable to speculate that cryopreservation of tissues in the clinic will be more practical than direct primary isolation of stem cells, which would require additional equipment and personnel (Seo et al., 2005). A cryobank of these cells would add great flexibility to their use by allowing, among other things, shipment of cells to investigators and/or clinicians and adequate time for donor characterization and/or potential testing. To achieve this overall goal, we propose to begin with the following Specific Aims: (I) Optimization of collection, transportation and processing of extracted teeth; (II) Optimization of cryopreservation of tooth derived stem cells; and (III) Final development of optimized, cGTP protocols for development of a tooth stem cell bank for distribution and use. Ultimate feasibility of developing a cryobank of DPSCs will be considered achieved if e90% functional recovery of these cells is retained using the most sensitive assay available when compared to their unfrozen counterparts. Public Health Significance: Stem cells can develop into different tissues types in the body. Post-natal, or adult stem cells offer an alternative to obtaining stem cells from embryos. Such stem cells exist in human teeth, but more research is required before these cells can have direct clinical use. A bank of frozen stem cells from teeth would be ideal to facilitate this research. This proposed project would optimize methods for processing and freezing these cells for ease of distribution for research, testing, and eventually clinical use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel strategies for storage and recovery of cadaveric bone marrow stem cells
-
批准号:9910145
-
项目类别:
-
资助金额:$77.87万
-
财政年份:2018
-
负责人:ERIK J. WOODS
-
依托单位:
OssioStem-matched multipotent MSC (M3): banked, low passage bone marrow MSC for treatment of hematopoietic acute radiation syndrome.
-
批准号:9913377
-
项目类别:
-
资助金额:$49.5万
-
财政年份:2018
-
负责人:ERIK J. WOODS
-
依托单位:
OssioStem-matched multipotent MSC (M3): banked, low passage bone marrow MSC for treatment of hematopoietic acute radiation syndrome.
-
批准号:10392485
-
项目类别:
-
资助金额:$57.28万
-
财政年份:2018
-
负责人:ERIK J. WOODS
-
依托单位:
Novel strategies for storage and recovery of cadaveric bone marrow stem cells
-
批准号:10116454
-
项目类别:
-
资助金额:$68.73万
-
财政年份:2018
-
负责人:ERIK J. WOODS
-
依托单位:
OssioStem-matched multipotent MSC (M3): banked, low passage bone marrow MSC for treatment of hematopoietic acute radiation syndrome.
-
批准号:10271661
-
项目类别:
-
资助金额:$6.85万
-
财政年份:2018
-
负责人:ERIK J. WOODS
-
依托单位:
Novel Disaccharide-Based Cryopreservation Approach for Stable, -80°C Storage of Stem Cells
-
批准号:9410055
-
项目类别:
-
资助金额:$23.91万
-
财政年份:2017
-
负责人:ERIK J. WOODS
-
依托单位:
Optimizing Industrial-Scale GMP Processes for Recovering and Banking Deceased Donor Bone Marrow
-
批准号:9926831
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2017
-
负责人:ERIK J. WOODS
-
依托单位:
A Novel, Inexpensive Cryopreservation System for Stable -80 degree C Storage of A
-
批准号:8199764
-
项目类别:
-
资助金额:$15.43万
-
财政年份:2011
-
负责人:ERIK J. WOODS
-
依托单位:
Therapeutic Angiogenesis by Universal Donor Endometrial Regenerative Cells
-
批准号:7804372
-
项目类别:
-
资助金额:$14.24万
-
财政年份:2010
-
负责人:ERIK J. WOODS
-
依托单位:
A Novel Device Design for Sperm Cryopreservation
-
批准号:7665250
-
项目类别:
-
资助金额:$13.73万
-
财政年份:2009
-
负责人:ERIK J. WOODS
-
依托单位:
A NOVEL APPROACH TO GMP PRODUCTION, CRYOPRESERVATION AND DISTRIBUTION OF TOOTH DE
-
批准号:7935375
-
项目类别:
-
资助金额:$47.18万
-
财政年份:2009
-
负责人:ERIK J. WOODS
-
依托单位:
AUTOMATED CLOSED SYSTEM FOR DMSO REMOVAL FROM PERIPHERAL BLOOD STEM CELLS
-
批准号:7326973
-
项目类别:
-
资助金额:$51.86万
-
财政年份:2006
-
负责人:ERIK J. WOODS
-
依托单位:
AUTOMATED CLOSED SYSTEM FOR DMSO REMOVAL FROM PERIPHERAL BLOOD STEM CELLS
-
批准号:7494589
-
项目类别:
-
资助金额:$48.52万
-
财政年份:2006
-
负责人:ERIK J. WOODS
-
依托单位:
AUTOMATED CLOSED SYSTEM FOR DMSO REMOVAL FROM PERIPHERAL BLOOD STEM CELLS
-
批准号:7054977
-
项目类别:
-
资助金额:$13.37万
-
财政年份:2006
-
负责人:ERIK J. WOODS
-
依托单位:
NOVEL SELF-NUCLEATING CRYOSTROGE DEVICES
-
批准号:6790294
-
项目类别:
-
资助金额:$10.75万
-
财政年份:2004
-
负责人:ERIK J. WOODS
-
依托单位:
A NOVEL FROZEN STORAGE SYSTEM FOR CORD BLOOD STEM CELLS
-
批准号:6698852
-
项目类别:
-
资助金额:$49.88万
-
财政年份:2003
-
负责人:ERIK J. WOODS
-
依托单位:
A NOVEL FROZEN STORAGE SYSTEM FOR CORD BLOOD STEM CELLS
-
批准号:6587002
-
项目类别:
-
资助金额:$50.16万
-
财政年份:2003
-
负责人:ERIK J. WOODS
-
依托单位:
A NOVEL FROZEN-STORAGE SYSTEM FOR CORD BLOOD STEM CELLS
-
批准号:6211991
-
项目类别:
-
资助金额:$9.91万
-
财政年份:2000
-
负责人:ERIK J. WOODS
-
依托单位:
EXPANSION OF PANCREATIC ISLETS USING A NOVEL BIOMATERIAL
-
批准号:6310496
-
项目类别:
-
资助金额:$38.85万
-
财政年份:1999
-
负责人:ERIK J. WOODS
-
依托单位:
EXPANSION OF PANCREATIC ISLETS USING A NOVEL BIOMATERIAL
-
批准号:6517566
-
项目类别:
-
资助金额:$38.67万
-
财政年份:1999
-
负责人:ERIK J. WOODS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: